Pharma
Biden administration reportedly plans to reclassify cannabis as Schedule III drug
The move would allow pharmaceutical companies to sell and distribute medical cannabis.
The move would allow pharmaceutical companies to sell and distribute medical cannabis.
Valentina Milanova founded the company in 2018 to improve healthcare for women and people assigned female at birth.
It’d take federal policy changes to require drug labels to warn about potential cannabis interactions.
Patients halved daily opioid use after eight months on medical cannabis.
How doctors and hospitals can prepare for cannabis-related outcomes.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.